drugset / Trial / NCT05221138
Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This study is a single-center, randomized, open-label, three-period crossover design, the objective is to evaluate the pharmacokinetics and safety of VV116 tablets, which are orally administered to Chinese healthy volunteers after fasting, standard diet or high-fat diet.
Timeline
- Start
- 2021-12-30
- Primary completion
- 2022-01-19
- Completion
- 2022-01-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | REMIDEVIR | Small molecule | 400 mg | Oral |
Indications
No indication recorded.